Vicarious Surgical RBOT
OTC RBOT
$0.04 -0.01 (-17.05%)
At close: Aug 19, 2026 · 3:39 PM UTC

Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021)

Vicarious Surgical (RBOT) posted quarterly Income from Non-Controlling Interests of -$21.0 million for Q2 2021, down 78652.22% year-over-year from N/an in Q2 2020, and down 78652.22% quarter-over-quarter from -$26704.0 in Q2 2020.

Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends

Vicarious Surgical (RBOT) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$21.0 million the latest figure, recorded in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn -
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn -
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -500,000.00
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 2.32 Mn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 900,000.00
10 Vicarious Surgical 196,495.36 -14.84 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -21.03 Mn
Jun 30, 2020 -26,704.00